This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1zsd

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1zsd.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1zsd.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1zsd| PDB=1zsd | SCENE= }}
{{STRUCTURE_1zsd| PDB=1zsd | SCENE= }}
-
'''Crystal Structure Of HLA-B*3501 Presenting an 11-Mer EBV Antigen EPLPQGQLTAY'''
+
===Crystal Structure Of HLA-B*3501 Presenting an 11-Mer EBV Antigen EPLPQGQLTAY===
-
==Overview==
+
<!--
-
MHC class I molecules generally present peptides of 8-10 aa long, forming an extended coil in the HLA cleft. Although longer peptides can also bind to class I molecules, they tend to bulge from the cleft and it is not known whether the TCR repertoire has sufficient plasticity to recognize these determinants during the antiviral CTL response. In this study, we show that unrelated individuals infected with EBV generate a significant CTL response directed toward an HLA-B*3501-restricted, 11-mer epitope from the BZLF1 Ag. The 11-mer determinant adopts a highly bulged conformation with seven of the peptide side chains being solvent-exposed and available for TCR interaction. Such a complex potentially creates a structural challenge for TCR corecognition of both HLA-B*3501 and the peptide Ag. Surprisingly, unrelated B*3501 donors recognizing the 11-mer use identical or closely related alphabeta TCR sequences that share particular CDR3 motifs. Within the small number of dominant CTL clonotypes observed, each has discrete fine specificity for the exposed side chain residues of the peptide. The data show that bulged viral peptides are indeed immunogenic but suggest that the highly constrained TCR repertoire reflects a limit to TCR diversity when responding to some unusual MHC peptide ligands.
+
The line below this paragraph, {{ABSTRACT_PUBMED_16148129}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 16148129 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_16148129}}
==Disease==
==Disease==
Line 41: Line 45:
[[Category: Human leukocyte antigen]]
[[Category: Human leukocyte antigen]]
[[Category: Major histocompatibility complex i]]
[[Category: Major histocompatibility complex i]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 18:00:54 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 00:33:03 2008''

Revision as of 21:33, 27 July 2008

Image:1zsd.png

Template:STRUCTURE 1zsd

Contents

Crystal Structure Of HLA-B*3501 Presenting an 11-Mer EBV Antigen EPLPQGQLTAY

Template:ABSTRACT PUBMED 16148129

Disease

Known disease associated with this structure: Hypoproteinemia, hypercatabolic OMIM:[109700]

About this Structure

1ZSD is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

Reference

CTL recognition of a bulged viral peptide involves biased TCR selection., Miles JJ, Elhassen D, Borg NA, Silins SL, Tynan FE, Burrows JM, Purcell AW, Kjer-Nielsen L, Rossjohn J, Burrows SR, McCluskey J, J Immunol. 2005 Sep 15;175(6):3826-34. PMID:16148129

Page seeded by OCA on Mon Jul 28 00:33:03 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1zsd"
Personal tools